tbuckley/cabot-search huggingface dataset:
Regulatory T cells limit age-associated retinal inflammation and neurodegeneration
Authors: María Llorián-Salvador, Alerie G. de la Fuente, Christopher E. McMurran, Amy Dashwood, James Dooley, Adrian Liston, Rosana Penalva, Yvonne Dombrowski, Alan W. Stitt, Denise C. Fitzgerald
Journal: Molecular Neurodegeneration (2024)

Ageing is the principal risk factor for retinal degenerative diseases, which are the commonest cause of blindness in the developed countries. These conditions include age-related macular degeneration or diabetic retinopathy. Regulatory T cells play a vital role in immunoregulation of the nervous system by limiting inflammation and tissue damage in health and disease. Because the retina was long-considered an immunoprivileged site, the precise contribution of regulatory T cells in retinal homeostasis and in age-related retinal diseases remains unknown.
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial
Authors: Afsaneh Alavi, Errol P Prens, Alexa B Kimball, John W Frew, James G Krueger, Sutirtha Mukhopadhyay, Heli Gao, Usha Ranganathan, Nathalie B Ivanoff, Ana C Hernandez Daly, Christos C Zouboulis
Journal: British Journal of Dermatology (2024)

Abstract Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a considerable disease burden. Existing treatment options are limited and often suboptimal; a high unmet need exists for effective targeted therapies. Objectives To explore the effects of spesolimab treatment in patients with HS. Methods This randomized double-blind placebo-controlled proof-of-clinical-concept (PoCC) study was conducted at 25 centres across 12 countries from 3 May 2021 to 21 April 2022. Patients had moderate-to-severe HS for ≥ 1 year before enrolment. Patients were randomized (2 : 1) to receive a loading dose of 3600-mg intravenous spesolimab (1200 mg at weeks 0, 1 and 2) or matching placebo, followed by maintenance with either 1200-mg subcutaneous spesolimab every 2 weeks from weeks 4 to 10 or matching placebo. The primary endpoint was the percentage change from baseline in total abscess and inflammatory nodule (AN) count at week 12. Secondary endpoints were the absolute change from baseline in the International Hidradenitis Suppurativa Severity Score System (IHS4), percentage change from baseline in draining tunnel (dT) count, the proportion of patients achieving a dT count of 0, absolute change from baseline in the revised Hidradenitis Suppurativa Area and Severity Index (HASI-R), the proportion of patients achieving Hidradenitis Suppurativa Clinical Response (HiSCR50), the proportion of patients with ≥ 1 flare (all at week 12) and patient-reported outcomes. Results In this completed trial, randomized patients (n = 52) received spesolimab (n = 35) or placebo (n = 17). The difference vs. placebo in least squares mean is reported. At week 12, the percentage change in total AN count was similar between treatment arms: –4.1% [95% confidence interval (CI) –31.7 to 23.4]. There was greater numerical improvement in the spesolimab arm, as measured by IHS4 (13.9, 95% CI –25.6 to –2.3); percentage change from baseline in dT count (–96.6%, 95% CI –154.5 to –38.8); and the proportion of patients achieving a dT count of 0 (18.3%, 95% CI –7.9 to 37.5). Spesolimab treatment also improved HASI-R and HiSCR50 vs. placebo. Spesolimab demonstrated a favourable safety profile, similar to that observed in trials in other diseases. Conclusions This exploratory PoCC study supports the development of spesolimab as a new therapeutic option in HS.
Earl Grey: A Fully Automated User-Friendly Transposable Element Annotation and Analysis Pipeline
Authors: Tobias Baril, James Galbraith, Alex Hayward
Journal: Molecular Biology and Evolution (2024)

Transposable elements (TEs) are major components of eukaryotic genomes and are implicated in a range of evolutionary processes. Yet, TE annotation and characterization remain challenging, particularly for nonspecialists, since existing pipelines are typically complicated to install, run, and extract data from. Current methods of automated TE annotation are also subject to issues that reduce overall quality, particularly (i) fragmented and overlapping TE annotations, leading to erroneous estimates of TE count and coverage, and (ii) repeat models represented by short sections of total TE length, with poor capture of 5' and 3' ends. To address these issues, we present Earl Grey, a fully automated TE annotation pipeline designed for user-friendly curation and annotation of TEs in eukaryotic genome assemblies. Using nine simulated genomes and an annotation of Drosophila melanogaster, we show that Earl Grey outperforms current widely used TE annotation methodologies in ameliorating the issues mentioned above while scoring highly in benchmarking for TE annotation and classification and being robust across genomic contexts. Earl Grey provides a comprehensive and fully automated TE annotation toolkit that provides researchers with paper-ready summary figures and outputs in standard formats compatible with other bioinformatics tools. Earl Grey has a modular format, with great scope for the inclusion of additional modules focused on further quality control and tailored analyses in future releases.
TIP24-197: R Role of [99m Tc] DTPA-bis (Choline) in Evaluation of Breast Cancer: A Prospective Diagnostic Trial in Progress at AIIMS Rishikesh
Authors: Nikhil K. Gupta, Vandana Dhingra, Puja P. Hazari, Shranav Jha, Sanjith LS
Journal: Journal of the National Comprehensive Cancer Network (2024)

"TIP24-197: R Role of [99m Tc] DTPA-bis (Choline) in Evaluation of Breast Cancer: A Prospective Diagnostic Trial in Progress at AIIMS Rishikesh" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CLO24-076: Prolonged Anesthesia as a Risk Factor for Extended Length of Stay Following Craniotomy for Primary Glioma
Authors: Samantha Schimmel, Jonah Gordon, Adam Alayli, Gavin Lockard, Anshruta Dhanashekar, Vishnu V. Iyer, Bassel El Sayed, Samuel Bauserman, Nasrin Aldawoodi, Allan Escher, Rahul Mhaskar, Nam D. Tran
Journal: Journal of the National Comprehensive Cancer Network (2024)
CLO24-055: Outcomes With Sacituzumab Govitecan in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
Authors: Moazzam Shahzad, Jawad Noor, Muhammad Fareed Khalid, Muhammad Kashif Amin, Mehnaz Nadeem, Ahmad Basharat, Michael Jaglal
Journal: Journal of the National Comprehensive Cancer Network (2024)
EPR24-108: The Effect of Exercise on Cardiotoxicity in Women With Breast Cancer Receiving Anthracycline-Based Chemotherapy: A Systematic Review and Meta-Analysis
Authors: Cho Han Chiang, Yu-Cheng Chang, Yulin Haw, Jia Yi Tan, Cho-Hsien Chiang, Yuan Ping Hsia, Cho-Hung Chiang
Journal: Journal of the National Comprehensive Cancer Network (2024)

"EPR24-108: The Effect of Exercise on Cardiotoxicity in Women With Breast Cancer Receiving Anthracycline-Based Chemotherapy: A Systematic Review and Meta-Analysis" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-133: Real-World (RW) Effectiveness of Erythropoiesis-Stimulating Agents (ESAs) After Luspatercept in Patients (pts) With Myelodysplastic Syndromes (MDS): A Retrospective Analysis of a Large Healthcare Claims Database in the United States
Authors: Kirollos S. Hanna, Rui Song, Samantha Slaff, Enrico Zanardo, Lynn Huynh, Manasi Mohan, Megan Pinaire, Derek Tang, Mihran Yenikomshian, Victoria Barghout, Adeola Y. Makinde, Kashyap Patel
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-133: Real-World (RW) Effectiveness of Erythropoiesis-Stimulating Agents (ESAs) After Luspatercept in Patients (pts) With Myelodysplastic Syndromes (MDS): A Retrospective Analysis of a Large Healthcare Claims Database in the United States" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CLO24-059: The Impact of Proton Pump Inhibitors on Palbociclib in Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis
Authors: Yu-Cheng Chang, Junmin Song, Kuan-Yu Chi, Pei-Chin Chen, Aarushi Sudan, Chin-Hsuan Huang, Yu Chang
Journal: Journal of the National Comprehensive Cancer Network (2024)

"CLO24-059: The Impact of Proton Pump Inhibitors on Palbociclib in Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CLO24-075: Surgeon Administered Transversus Abdominis Plane Block With Local Anesthetic Infiltration Versus Transversus Abdominis Plane Block Following Robot-Assisted Radical Prostatectomy
Authors: Pushan Prabhakar, Arjun Pon Avudaiappan, Daniel Ajabshir, Orlando Brito Martinez, Ahmed Eldefrawy, Jorge Caso, Murugesan Manoharan
Journal: Journal of the National Comprehensive Cancer Network (2024)

"CLO24-075: Surgeon Administered Transversus Abdominis Plane Block With Local Anesthetic Infiltration Versus Transversus Abdominis Plane Block Following Robot-Assisted Radical Prostatectomy" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-153: Real-World Clinical Outcomes of First-Line Therapies and Treatment Regimens for BRAF-Mutant Advanced/Metastatic Melanoma: Retrospective Observational Study
Authors: Ruixuan Jiang, Geoffrey Johnson, Emilie Scherrer, John Kang, Kathleen M. Aguilar, Rohini Singh, Eric D. Whitman
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-153: Real-World Clinical Outcomes of First-Line Therapies and Treatment Regimens for BRAF-Mutant Advanced/Metastatic Melanoma: Retrospective Observational Study" published on 05 Apr 2024 by National Comprehensive Cancer Network.
YIA24-005: MAIT Cells are Reduced in Anorectal Mucosal Melanomas Compared to Cutaneous Melanoma GI Metastases
Authors: Richard Tobin, Elizabeth N. Katsnelson, Kasey L. Couts, Andrea Spengler, Liyen Loh, Laurent Gapin, Martin D. McCarter
Journal: Journal of the National Comprehensive Cancer Network (2024)
HSR24-138: Real-World Treatment (tx) Patterns and Outcomes for First-Line (1L) Novel Hormonal Agent (NHA) Naïve Metastatic Castration Resistant Prostate Cancer (mCRPC) Including in Black and/or African American (BAA) Patients (Pts)
Authors: Emily Nash Smyth, Samuel Whipple, Mark Guinter, Nadine Haddad, Wenxian Piao, Zhanglin Cui, Arjun Balar
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-138: Real-World Treatment (tx) Patterns and Outcomes for First-Line (1L) Novel Hormonal Agent (NHA) Naïve Metastatic Castration Resistant Prostate Cancer (mCRPC) Including in Black and/or African American (BAA) Patients (Pts)" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CLO24-082: A National Cancer Data Base (NCDB) Analysis of Prognostic Factors in Metastatic Triple-Negative Breast Cancer (TNBC)
Authors: Priyal Agarwal, Amulya Yellala, Samia Asif, Valerie K. Shostrom, Meghana Kesireddy
Journal: Journal of the National Comprehensive Cancer Network (2024)
CLO24-068: The Role of Obesity in Influencing Patient Survival in Metastatic Renal Cell Carcinoma Patients Receiving Immunotherapy: A Systematic Review and Meta-Analysis.
Authors: Chalothorn Wannaphut, Sakditad Saowapa, Natchaya Polpichai, Pharit Siladech, Manasawee Tanariyakul, Phuuwadith Wattanachayakul, Pakin Lalitnithi
Journal: Journal of the National Comprehensive Cancer Network (2024)

"CLO24-068: The Role of Obesity in Influencing Patient Survival in Metastatic Renal Cell Carcinoma Patients Receiving Immunotherapy: A Systematic Review and Meta-Analysis." published on 05 Apr 2024 by National Comprehensive Cancer Network.
EPR24-121: Trends in the Incidence and Mortality of Metastatic Epidural Spinal Cord Compression: A Ten-Year Population-Based Study
Authors: Ayobami Olafimihan, Inimfon Jackson, Stanley Ozogbo, Jeremiah Bello, Praise Fawehinmi, Hafeez Shaka
Journal: Journal of the National Comprehensive Cancer Network (2024)
HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States
Authors: Xiaoqin Yang, Rose Chang, Theresa Dettling, Raj Desai, Chi Gao, Azeem Banatwala, Sydney Ng, Sama Ahsan, Mei Sheng Duh
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-155: Disparities in Real-World Screening Mammography Compliance Rates by Body Mass Index and Mobility-Restricting Diagnosis—A Commercial Claims-Based Analysis
Authors: Julia Olsen, Scott Pohlman, Jason Shames
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-155: Disparities in Real-World Screening Mammography Compliance Rates by Body Mass Index and Mobility-Restricting Diagnosis—A Commercial Claims-Based Analysis" published on 05 Apr 2024 by National Comprehensive Cancer Network.
QIM24-186: Surviving and Thriving After Lung Cancer: A Pilot Project to Understand Physician Perspectives on the Approach to Lung Cancer Survivorship Care at Weill Cornell Medicine Medical Oncology
Authors: Abha Kulkarni, Christine Garcia
Journal: Journal of the National Comprehensive Cancer Network (2024)

"QIM24-186: Surviving and Thriving After Lung Cancer: A Pilot Project to Understand Physician Perspectives on the Approach to Lung Cancer Survivorship Care at Weill Cornell Medicine Medical Oncology" published on 05 Apr 2024 by National Comprehensive Cancer Network.
BPI24-023: Empirical Study to Estimate Real World Impact of Delay in Adjuvant Treatment on Healthcare Resource Utilization and Cost Burden
Authors: Tianyuan Hu, Arunav Saikia, Atharv Sharma, Priyanka Halder, Manu Prasad, Prabhakar Gaur, Venkata Sai Sumanth Pulluri, Stuti Jha
Journal: Journal of the National Comprehensive Cancer Network (2024)

"BPI24-023: Empirical Study to Estimate Real World Impact of Delay in Adjuvant Treatment on Healthcare Resource Utilization and Cost Burden" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-152: Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018–2021): A Review of Criticism and Concerns in Comments From Regulators
Authors: Erin Comerford, Lindsey Norcross, Medha Sasane, Ying Zheng, Ari Gnanasakthy
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-152: Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018–2021): A Review of Criticism and Concerns in Comments From Regulators" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CRE24-044: Response to Dabrafenib and Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Metastatic Non–Small Cell Lung Cancer
Authors: John Sharp, Daniel Jones, Julia Rotow, Panos Fidias, Erin Bertino, Dwight Owen
Journal: Journal of the National Comprehensive Cancer Network (2024)

"CRE24-044: Response to Dabrafenib and Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Metastatic Non–Small Cell Lung Cancer" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-163: Comparative Assessment of Social Determinants of Health in Community and Academic Hospitals for Patients Diagnosed With Hepatocellular Carcinoma
Authors: Elham Nasrollahi, Adalberto Guzman, Anas Atrash
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-163: Comparative Assessment of Social Determinants of Health in Community and Academic Hospitals for Patients Diagnosed With Hepatocellular Carcinoma" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CLO24-080: Association Between Primary Tumor Size and Prognosis in De Novo Metastatic Renal Cell Carcinoma in Patients Who Underwent First Line Immunotherapy-Based Therapy: Real World Data Analysis
Authors: Insija Ilyas Selene, Roshmita Bardhan, Rani Jayswal, Amina Dhahri, Jennifer C. Torres Yee, Heidi L. Weiss, Kimberly D. Ratliff, Zin Myint
Journal: Journal of the National Comprehensive Cancer Network (2024)

"CLO24-080: Association Between Primary Tumor Size and Prognosis in De Novo Metastatic Renal Cell Carcinoma in Patients Who Underwent First Line Immunotherapy-Based Therapy: Real World Data Analysis" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-130: Real-World Outcomes in Patients With Burkitt Lymphoma in a Safety-Net Health System
Authors: Maria Lee, Jun Y. Jiang, Chijioke Nze, Danielle Guffey, Rockbum Kim, Abiodun O. Oluyomi, Omar Rosales, Raka Bandyo, Courtney N. Miller-Chism, Mark M. Udden, Martha P. Mims, Hilary Ma, Gustavo A. Rivero, Akiva Diamond, Purnima S. Teegavarapu, Christopher R. Flowers, Ang Li, Sara Taveras Alam
Journal: Journal of the National Comprehensive Cancer Network (2024)
BPI24-018: Quality Recommendations for the Management of Cutaneous Squamous Cell Carcinoma (CSCC)
Authors: Eva Muñoz, Javier Cañueto Álvarez, Josep Oriol Bermejo Segú, Almudena García Castaño, Vanessa Gabriela Jerviz Guía, Ana María López López, Susana Puig Sardá, Onofre Sanmartín Jiménez, Ainara Soria Rivas, Paula Gratal, Teresa Pardo, Alvaro Rogado, Alfonso Berrocal
Journal: Journal of the National Comprehensive Cancer Network (2024)
HSR24-126: “Share the Fear”: Communication Concerns of Parents With Cancer With Dependent Children for Their Co-Parent: A Qualitative Study
Authors: Cinzia Caparso, Zoe Bowen, Sung Won Choi
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-126: "Share the Fear": Communication Concerns of Parents With Cancer With Dependent Children for Their Co-Parent: A Qualitative Study" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CLO24-066: Cemiplimab Use in Advanced Cutaneous Squamous Cell Carcinoma and Non–Small Cell Lung Cancer: Risk Factors Associated With Mortality
Authors: Cesar Simbaqueba Clavijo, Mehmet Altan, Maria Franco-Vega, Melvin Rivera, Anisha Patel
Journal: Journal of the National Comprehensive Cancer Network (2024)

"CLO24-066: Cemiplimab Use in Advanced Cutaneous Squamous Cell Carcinoma and Non–Small Cell Lung Cancer: Risk Factors Associated With Mortality" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CLO24-062: Aneuploid Epcam + Disseminated Tumor Cells (DTCs) Correlated With Liver Metastasis and Independently Predict Poor Survival in Small Cell Lung Cancer
Authors: Tongmei Zhang, Ying Wang, Hongxia Li, Baohua Lu, Yuan Gao, Yanxia Liu, Lina Zhang, Mingming Hu, Hongmei Zhang
Journal: Journal of the National Comprehensive Cancer Network (2024)

"CLO24-062: Aneuploid Epcam + Disseminated Tumor Cells (DTCs) Correlated With Liver Metastasis and Independently Predict Poor Survival in Small Cell Lung Cancer" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CRE24-033: Complete Remission of Microsatellite Instability–High (MSI-H) Oligometastatic Poorly Differentiated Colon Adenocarcinoma After a Single Dose of Immunotherapy
Authors: Christine Jane Kurian, Danny Markabawi
Journal: Journal of the National Comprehensive Cancer Network (2024)

"CRE24-033: Complete Remission of Microsatellite Instability–High (MSI-H) Oligometastatic Poorly Differentiated Colon Adenocarcinoma After a Single Dose of Immunotherapy" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-170: Utilization of Biomarker Testing and Biomarker-Driven Targeted Therapy Among Patients With Metastatic Non–Small Cell Lung Cancer
Authors: Nicole J. Zhang, Julie Wiedower Kaylor, Karen M. Stockl, Jacqueline Lekostaj, Jamie Tucker, Shaun P. Forbes, Julia M. Certa, Caroline Weipert, Keelia Clemens, Lucy Langer
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-170: Utilization of Biomarker Testing and Biomarker-Driven Targeted Therapy Among Patients With Metastatic Non–Small Cell Lung Cancer" published on 05 Apr 2024 by National Comprehensive Cancer Network.
EPR24-122: Mesothelioma: Trends in Palliative Care Utilization in Hospitalized Patients, a National Inpatient Sample (NIS) Study (2016–2020)
Authors: Sangam Sangam, Marco Bermudez, Francisco Gallegos Koyner, Tripti Jain, Shorabh Sharma, Sorab Gupta
Journal: Journal of the National Comprehensive Cancer Network (2024)

"EPR24-122: Mesothelioma: Trends in Palliative Care Utilization in Hospitalized Patients, a National Inpatient Sample (NIS) Study (2016–2020)" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-139: Patient-Reported Outcome Measures Used in Patients With Chronic Phase–Chronic Myeloid Leukemia: A Systematic Review of the Literature
Authors: Kathryn E. Flynn, Lovneet Saini, Aditi Kataria, Kejal Jadhav, Daisy Yang, David Wei
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-139: Patient-Reported Outcome Measures Used in Patients With Chronic Phase–Chronic Myeloid Leukemia: A Systematic Review of the Literature" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-125: A Narrative Review on Geriatric Assessment and Outcomes in Diffuse Large B-Cell Lymphoma: Differentiating Fit, Frail, and Unfit Patients
Authors: Ekaterina Proskuriakova, Iuliia Kovalenko, Chandi Garg, Megan Adams, Pam G. Khosla
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-125: A Narrative Review on Geriatric Assessment and Outcomes in Diffuse Large B-Cell Lymphoma: Differentiating Fit, Frail, and Unfit Patients" published on 05 Apr 2024 by National Comprehensive Cancer Network.
HSR24-147: Non-Optimal Treatment in Early-Line Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Tyrosine Kinase Inhibitors (TKI): A Claims Data Analysis
Authors: Vamsi Kota, David Wei, Daisy Yang, Hela Romdhani, Dominick Latremouille-Viau, Annie Guérin, Kejal Jadhav
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-147: Non-Optimal Treatment in Early-Line Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Tyrosine Kinase Inhibitors (TKI): A Claims Data Analysis" published on 05 Apr 2024 by National Comprehensive Cancer Network.
BIO24-030: Unifying Multimodal Data, Time Series Analytics, and Contextual Medical Memory: Introducing MINDS as an Oncology-Centric Cloud-Based Platform
Authors: Aakash Tripathi, Asim Waqas, Ghulam Rasool
Journal: Journal of the National Comprehensive Cancer Network (2024)

"BIO24-030: Unifying Multimodal Data, Time Series Analytics, and Contextual Medical Memory: Introducing MINDS as an Oncology-Centric Cloud-Based Platform" published on 05 Apr 2024 by National Comprehensive Cancer Network.
CRE24-036: Liver-ing on a Prayer: A Rare Case of Hepatocellular Carcinoma With Metastasis to the Thyroid
Authors: Rachel Truong, Odelvys Granela, Shelby Ploucher, Alyssa Obermiller, T. Van Anh, Brian Shaw, Jacqueline N. Kropf
Journal: Journal of the National Comprehensive Cancer Network (2024)
HSR24-166: Implementation of an Integrated Supportive Care Medicine Consultation Service Within a Gastrointestinal Cancer Clinic: Timeliness of Referrals and Patient Access
Authors: Dena Berhan, Nicole Nardella, Adrianna Oraiqat, Denny Lu, Sarah Goodchild, Terry Gruchow, Young Chang, Sahana Rajasekhara, Pamela Hodul
Journal: Journal of the National Comprehensive Cancer Network (2024)

"HSR24-166: Implementation of an Integrated Supportive Care Medicine Consultation Service Within a Gastrointestinal Cancer Clinic: Timeliness of Referrals and Patient Access" published on 05 Apr 2024 by National Comprehensive Cancer Network.
PCO24-175: Immune Cell Dynamics After Radiotherapy for Oligometastatic Prostate Cancer
Authors: Sophia C. Kamran, Yukako Otani, David Qi, Isabella Rose Pompa, Richard Kuo Dzeng, Rea Pittie, Ella Chung, Keisuke Otani, Jennifer Y. Wo, Anthony L. Zietman, Patrick M. Reeves, Eliezer M. Van Allen, Jason A. Efstathiou, David T. Miyamoto
Journal: Journal of the National Comprehensive Cancer Network (2024)